fashion -WSS

fashion

author：leisure time 2025-09-30 16:23:28 - browse：98

research funding, medical devices — APStock

WASHINGTON — A federal district judge on Monday granted the Biden administration’s request to dismiss a lawsuit challenging Medicare’s new drug price negotiation program from the drug industry lobbying organization PhRMA.

The move is an early but positive sign for the Biden administration in a legal fight that could stretch for years, as a host of major drugmakers, including Merck, Bristol Myers Squibb, and Johnson & Johnson, have also filed lawsuits over the constitutionality of Medicare’s new powers. The first round of drug negotiations is ongoing, and a judge heard oral arguments in a challenge brought by AstraZeneca just last month.

Newsletters

Sign up for D.C. Diagnosis

Washington never stops. Cut through the noise with our essential updates on health care politics and policy

Please enter a valid email address. Privacy Policy

The National Infusion Center Association and the Global Colon Cancer Association are also plaintiffs in PhRMA’s lawsuit. The judge dismissed the National Infusion Center Association from the case because it did not have subject matter jurisdiction to bring the lawsuit. And because NICA was the only party to the lawsuit that resides in Texas, the judge tossed out the case in its entirety.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Ukraine and a new approach to mental health in war

WSS

CDC advisers recommend seasonal use of Pfizer RSV shot

New research casts further doubt on a common procedure used with IVF

DOJ reversal could clear way for Carroll's 1st lawsuit against Trump to proceed

Insurance companies sue energy corporation after it was blamed for helping start Colorado wildfire

HCA discloses massive data breach affecting 11 million patients

Why are Kaiser Permanente staff considering a strike?

entertainment

fashion

Sign up for D.C. Diagnosis

focus

The high cost of giving birth even with insurance

How AI helped researchers track recovery from depression

In Memoriam: Notable people who died in 2023

Readout LOUD podcast: possible new ALS drug, artificial wombs

Anesthesiologist group: stop taking Ozempic before surgery

Biotech stock slump in 2023: awaiting the turnaround

DIEP, the 'gold standard' of breast reconstruction, is under threat

Emergency workers more likely to restrain Black patients: study

ChatGPT in medicine: STAT answers readers' burning questions

CommonSpirit Health keeps growing, even as it loses money

explore

Retired US general questions alleged Putin, Prigozhin meeting

Study: Pain burden is higher in Black NFL players than white ones

What Congress can do to address the rural doctor shortage

What to know about OceanGate, the company behind the missing Titanic submersible

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Lecanemab for Alzheimer's is coming. Is the health system ready?

focus

explore

explore

Wikipedia